Skip to main content

Table 4 Proportion of change in outcome variable (HbA1c level at cut-off = 7%) after 3 months and after 6 months of intervention

From: Clinical efficacy of scaling and root planing with and without metronidazole on glycemic control: three-arm randomized controlled trial

Intervention groups

At 3rd month follow-up

p-value (chi2)*

At 6th month follow-up

p-value (chi2)*

HbA1c < 7%

HbA1c ≥ 7%

HbA1c < 7%

HbA1c ≥ 7%

Per-Protocol (PP) analysis

DT + OHI

0 (0)

24 (100)

0.020 (7.78)

2 (8.33)

22 (91.67)

0.061 (5.60)

SRP + OHI

5 (19.23)

21 (80.77)

9 (34.62)

17 (65.38)

SRP + MET + OHI

7 (29.17)

17 (70.83)

8 (33.33)

16 (66.67)

Intention-To-Treat (ITT) analysis

DT + OHI

1 (3.13)

31 (96.88)

0.045 (6.22)

2 (8.33)

22 (91.67)

0.061 (5.60)

SRP + OHI

5 (15.15)

28 (84.85)

9 (34.62)

17 (65.38)

SRP + MET + OHI

8 (25.0)

24 (75.0)

8 (33.33)

16 (66.67)

  1. *All Significant p-value < 0.05 calculated by chi-2 test have been made bold